Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

renal cell carcinoma

  • PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
    You have access
    PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
    Cristian Udovicich, Mathias Bressel, Jamil Manji, Muhammad Ali, Lewis Au, Arun A. Azad, James P. Buteau, Sarat Chander, David Chang, Renu Eapen, Nathan Lawrentschuk, Sidney M. Levy, Daniel Moon, Declan G. Murphy, Marlon Perera, Mark Shaw, Lavinia Spain, Ben Tran, Michael S. Hofman and Shankar Siva
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 531-536; DOI: https://doi.org/10.2967/jnumed.124.268639
  • Utility of PSMA PET/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis
    Open Access
    Utility of PSMA PET/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis
    Moe S. Sadaghiani, Saradha Baskaran, Michael A. Gorin, Steven P. Rowe, Jean-Claude Provost, Iryna Teslenko, Roman Bilyk, Hong An and Sara Sheikhbahaei
    Journal of Nuclear Medicine July 1, 2024, 65 (7) 1007-1012; DOI: https://doi.org/10.2967/jnumed.124.267417
  • A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
    You have access
    A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
    Marinus J. Hagens, Pim J. van Leeuwen, Maurits Wondergem, Thierry N. Boellaard, Francesco Sanguedolce, Daniela E. Oprea-Lager, Axel Bex, André N. Vis, Henk G. van der Poel and Laura S. Mertens; in collaboration with the EAU Section of Urological Imaging
    Journal of Nuclear Medicine June 1, 2024, 65 (6) 888-896; DOI: https://doi.org/10.2967/jnumed.123.267260
  • Diagnostic Accuracy of <sup>99m</sup>Tc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses
    You have access
    Diagnostic Accuracy of 99mTc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses
    Ashwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, Lisa R. Schmidt, Robert S. Figenshau, Farrokh Dehdashti and Richard L. Wahl
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 90-95; DOI: https://doi.org/10.2967/jnumed.122.264329
  • You have access
    Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
    Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
    Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570
  • You have access
    89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma
    Suzanne C. van Es, Adrienne H. Brouwers, Shekar V.K. Mahesh, Annemarie M. Leliveld-Kors, Igle J. de Jong, Marjolijn N. Lub-de Hooge, Elizabeth G.E. de Vries, Jourik A. Gietema and Sjoukje F. Oosting
    Journal of Nuclear Medicine June 1, 2017, 58 (6) 905-910; DOI: https://doi.org/10.2967/jnumed.116.183475
  • You have access
    Whole-Body PET/CT Evaluation of Tumor Perfusion Using Generator-Based 62Cu-Ethylglyoxal Bis(Thiosemicarbazonato)Copper(II): Validation by Direct Comparison to 15O-Water in Metastatic Renal Cell Carcinoma
    James W. Fletcher, Theodore F. Logan, Jacob A. Eitel, Carla J. Mathias, Yen Ng, Jeffrey L. Lacy, Gary D. Hutchins and Mark A. Green
    Journal of Nuclear Medicine January 1, 2015, 56 (1) 56-62; DOI: https://doi.org/10.2967/jnumed.114.148106
  • You have access
    89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment
    Sjoukje F. Oosting, Adrienne H. Brouwers, Suzanne C. van Es, Wouter B. Nagengast, Thijs H. Oude Munnink, Marjolijn N. Lub-de Hooge, Harry Hollema, Johan R. de Jong, Igle J. de Jong, Sanne de Haas, Stefan J. Scherer, Wim J. Sluiter, Rudi A. Dierckx, Alfons H.H. Bongaerts, Jourik A. Gietema and Elisabeth G.E. de Vries
    Journal of Nuclear Medicine January 1, 2015, 56 (1) 63-69; DOI: https://doi.org/10.2967/jnumed.114.144840
  • You have access
    Optical Imaging of Renal Cell Carcinoma with Anti–Carbonic Anhydrase IX Monoclonal Antibody Girentuximab
    Constantijn H.J. Muselaers, Alexander B. Stillebroer, Mark Rijpkema, Gerben M. Franssen, Egbert Oosterwijk, Peter F.A. Mulders, Wim J.G. Oyen and Otto C. Boerman
    Journal of Nuclear Medicine June 1, 2014, 55 (6) 1035-1040; DOI: https://doi.org/10.2967/jnumed.114.137356
  • You have access
    Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma
    Constantijn H.J. Muselaers, Alexander B. Stillebroer, Ingrid M.E. Desar, Marye J. Boers-Sonderen, Carla M.L. van Herpen, Mirjam C.A. de Weijert, Johan F. Langenhuijsen, Egbert Oosterwijk, William P.J. Leenders, Otto C. Boerman, Peter F.A. Mulders and Wim J.G. Oyen
    Journal of Nuclear Medicine February 1, 2014, 55 (2) 242-247; DOI: https://doi.org/10.2967/jnumed.113.131110
SNMMI

© 2025 SNMMI

Powered by HighWire